Impact of baseline cysts at the time of administration of gonadotropin-releasing hormone analog for in vitro fertilization

被引:0
|
作者
Zeyneloglu, HB
Isik, AZ
Kara, S
Senöz, S
Özcan, U
Gökmen, O
机构
[1] Dr ZT Burak Womens Hosp, Dept Reprod Endocrinol, Ankara, Turkey
[2] Dr ZT Burak Womens Hosp, IVF Unit, Ankara, Turkey
关键词
fertilization in vitro; ovarian cysts; gonadotropin-releasing hormone agonist; ovarian stimulation;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective-To assess the effects of cysts developed prior to the commencement of luteal phase gonadotropin-releasing-hormone-agonist (GnRH-a) in IVF cycles. Design-Retrospective analysis. Setting-In vitro fertilization program in a tertiary hospital infertility clinic. Patients-Women stimulated for IVF-ET. All stimulations were down-regulated with GnRH-a commenced on day 21 in a long protocol before gonadotropin stimulation. Main Outcome Measure-Pregnancy rate. Results-Twenty-five of 121 cycles had cysts >15 mm (20.6%); these were classified as baseline (nonfunctional) (n = 12) or corpus luteum (n = 13) cysts. They had significantly longer suppression periods and lower peak estradiol levels, and used more gonadotropins during stimulation. Cysts had no impact on the number of oocytes collected or fertilization and pregnancy rates. Patients with baseline cysts had a greater duration of suppression and required more gonadotropin than those with corpus luteum cysts or those without cysts. The cycle outcomes were similar between the groups, but baseline cyst formation is likely to increase the cost of IVF. Conclusion-These findings suggest that baseline cyst formation causes longer suppression duration and greater gonadotropin utilization, although an impact on pregnancy rates is unlikely.
引用
收藏
页码:300 / 305
页数:6
相关论文
共 50 条
  • [1] FOLLICLE CYSTS AFTER MENSTRUAL VERSUS MIDLUTEAL ADMINISTRATION OF GONADOTROPIN-RELEASING HORMONE ANALOG IN INVITRO FERTILIZATION
    HERMAN, A
    RONEL, R
    GOLAN, A
    NAHUM, H
    SOFFER, Y
    CASPI, E
    FERTILITY AND STERILITY, 1990, 53 (05) : 854 - 858
  • [2] FOLLICULAR AND LUTEAL CYSTS AFTER TREATMENT WITH GONADOTROPIN-RELEASING HORMONE ANALOG FOR INVITRO FERTILIZATION
    BENRAFAEL, Z
    BIDER, D
    MENASHE, Y
    MAYMON, R
    ZOLTI, M
    MASHIACH, S
    FERTILITY AND STERILITY, 1990, 53 (06) : 1091 - 1094
  • [3] The role of gonadotropin-releasing hormone antagonists in in vitro fertilization
    Diedrich, K
    Ludwig, M
    Felberbaum, RE
    SEMINARS IN REPRODUCTIVE MEDICINE, 2001, 19 (03) : 213 - 220
  • [4] Gonadotropin-releasing hormone antagonist in in vitro fertilization superovulation
    Seng, Shay Way
    Ong, Kee Jiet
    Ledger, W. L.
    WOMENS HEALTH, 2006, 2 (06) : 881 - 888
  • [5] OVARIAN HYPERSTIMULATION FOR IN VITRO FERTILIZATION PRECEDED BY PROLONGED ADMINISTRATION OF A GONADOTROPIN-RELEASING HORMONE AGONIST
    Tanbo, Tom
    Dale, Per Olav
    Abyholm, Thomas
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1990, 69 (04) : 333 - 337
  • [6] Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization
    Kolibianakis, EM
    Zikopoulos, K
    Smitz, J
    Camus, M
    Tournaye, H
    Van Steirteghem, AC
    Devroey, P
    FERTILITY AND STERILITY, 2004, 82 (01) : 223 - 226
  • [7] Dermatitis herpetiformis associated with administration of a gonadotropin-releasing hormone analog
    Yu, SS
    Connolly, MK
    Berger, TG
    McCalmont, TH
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (02) : S58 - S59
  • [8] ADMINISTRATION OF A GONADOTROPIN-RELEASING HORMONE ANALOG IN OLIGOZOOSPERMIC INFERTILE MALES
    BADENOCH, DF
    WAXMAN, J
    BOORMAN, L
    SIDHU, B
    MOORE, HD
    HOLT, WV
    BLANDY, JP
    ACTA ENDOCRINOLOGICA, 1988, 117 (02): : 265 - 267
  • [9] BASELINE OVARIAN CYST FORMATION FOLLOWING GONADOTROPIN-RELEASING HORMONE ANALOGUES: THEIR PREVALENCE AND IMPACT ON IN VITRO FERTILIZATION OUTCOME.
    Failor, C.
    Knudtson, J. E.
    Schenken, R. S.
    Robinson, R. D.
    FERTILITY AND STERILITY, 2016, 106 (03) : E200 - E200
  • [10] Gonadotropin-releasing hormone analog therapeutics
    Newton, Claire L.
    Riekert, Carmen
    Millar, Robert P.
    MINERVA GINECOLOGICA, 2018, 70 (05): : 497 - 515